Spinal cord stimulator (SCS) is also known as dorsal column
stimulator. The system comprises and an electric pulse generator.
Functioning of the spinal cord stimulator is based on the pain
management therapy. The spinal cord stimulator hinders transmission
of pain signals to the brain so that the brain does not identify the
pain. The device gives positive, symptomatic, and long-term effects
in cases of sciatica, cervical radiculopathy, failed back surgery
syndrome (FBSS), reflex sympathetic dystrophy, arachnoiditis, and
peripheral neuropathy. Spinal cord stimulation received approval from
the U.S. FDA in 1989 for indications such as nerve damage in the
trunk, arms, or legs. According to a study conducted by the Institute
of Medicine of The National Academies, 100 million people in the U.S.
suffer from chronic pain. Moreover, the study states that the
incidence rate of lower back pain is the maximum. Lower back pain
accounted for around 30% of all kinds of chronic pain.
The spinal cord stimulators market is large-sized and relatively
untouched. Spinal cord stimulators possess high potential to treat
widespread chronic back pain. The global spinal cord stimulators
market is anticipated to witness significant growth in the next few
years due to rising geriatric population, increasing demand for
minimally invasive surgeries, and technological advancements across
the world. In May 2015, Nevro Corporation received the U.S. FDA’s
approval for its Senza spinal cord stimulator (SCS) system. This
implantable and rechargeable system helps in relieving chronic pain
in the limbs and the trunks. The upcoming product innovations and new
product launches are expected to boost the market from 2017 to 2025.
However, factors such as unfavorable reimbursement scenario, lack of
trained professionals, and high cost of products and treatment are
hindering the market for spinal cord stimulators. According to a
survey conducted by ECRI Institute in January 2015,
The global spinal cord stimulators market has been classified based
on product, application, end-user, and geography. Based on product,
the market has been segmented into rechargeable spinal cord
stimulator systems and non-rechargeable spinal cord stimulator
systems. Compact size, user-friendly nature, and launch of new
rechargeable systems are some of the factors fueling the rechargeable
systems segment.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35741
Based on application, the global spinal cord stimulators market has
been divided into sciatica, failed back syndrome (FBS),
arachnoiditis, degenerative disk disease, and others. High prevalence
of chronic back pain and disk surgery and increasing demand for
devices providing rapid relief are major factors likely to increase
the demand for spinal cord stimulators during the forecast period.
The market is anticipated to witness high growth in the next few
years, due to rise in the number of health care organizations and
clinics and commercialization of products across the globe. Hospitals
is anticipated to be a major end-user segment of the SCS systems
market and is anticipated to dominate the market during the forecast
period.
Geographically, the global spinal cord stimulators market has been
classified into North America, Latin America, Europe, Asia Pacific,
and Middle East & Africa. The U.S. was the largest market in
terms of revenue in 2016. while the market in is likely to expand at
the most rapid pace during the forecast period.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=35741<ype=S
Boston Scientific, St. Jude Medical, Medtronic Plc, Nevro Corporation
are key players operating in the global market for spinal cord
stimulators. They are making investments in research activities to
launch new devices. Several new entrants such as Stimwave,
Greatbatch, Autonomic Technologies, Inc., and Cyberonics are planning
to expand in the global spinal cord stimulators market in the near
future.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment